Unknown

Dataset Information

0

2-(4-Bromo-benzo-yl)-1-ferrocenyl-spiro-[11H-pyrrolidizine-3,11'-indeno-[1,2-b]quinoxaline].

ABSTRACT: In the title compound, [Fe(C5H5)(C33H25BrN3O)], the fused four-ring system, 11H-indeno-[1,2-b]quinoxaline is essentially planar, with a maximum deviation of 0.087?(3)?Å from the least-squares plane of the attached benzene ring. The pyrrolidine rings adopt envelope conformation and make a dihedral angle of 51.76?(19)° with each other. The cyclopentadiene rings of the ferrocenyl moiety have an eclipsed conformation. The Br atom deviates by 0.0190?(9)?Å from the attached benzene ring. The mol-ecular structure features an intra-molecular C-H?N inter-action, which generates an S(8) ring motif. The crystal packing features C-H?O inter-actions, which generate R 2 (2)(18) centrosymmetric dimers, as well as C-H?? inter-actions.

SUBMITTER: Suhitha S 

PROVIDER: S-EPMC3884418 | biostudies-literature | 2013

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

2-(4-Bromo-benzo-yl)-1-ferrocenyl-spiro-[11H-pyrrolidizine-3,11'-indeno-[1,2-b]quinoxaline].

Suhitha Sivasubramanian S   Gunasekaran Krishnaswamy K   Sureshbabu Adukamparai Rajukrishnan AR   Raghunathan Raghavachary R   Velmurugan Devadasan D  

Acta crystallographica. Section E, Structure reports online 20130823 Pt 9

In the title compound, [Fe(C5H5)(C33H25BrN3O)], the fused four-ring system, 11H-indeno-[1,2-b]quinoxaline is essentially planar, with a maximum deviation of 0.087 (3) Å from the least-squares plane of the attached benzene ring. The pyrrolidine rings adopt envelope conformation and make a dihedral angle of 51.76 (19)° with each other. The cyclopentadiene rings of the ferrocenyl moiety have an eclipsed conformation. The Br atom deviates by 0.0190 (9) Å from the attached benzene ring. The mol-ecula  ...[more]

Similar Datasets

Unknown Crystal structure of 1-ferrocenyl-2-(4-methyl-benzo-yl)spiro-[11H-pyrrolidizine-3,11'-indeno[1,2-b]quinoxaline].
| S-EPMC4186081 | biostudies-other
Unknown 4-Ferrocenyl-1-methyl-3-benzoyl-spiro-[pyrrolidine-2,11'-indeno-[1,2-b]quinoxaline].
| S-EPMC3588807 | biostudies-other
Unknown 1',1''-Dimethyl-4'-(4-methyl-phen-yl)di-spiro-[11H-indeno-[1,2-b]quinoxaline-11,2'-pyrrolidine-3',3''-piperidin]-4''-one.
| S-EPMC3884467 | biostudies-literature
Unknown Crystal structure of 1',1''-dimethyl-4'-(4-cholorophen-yl)di-spiro-[11H-indeno[1,2-b]quinoxaline-11,2'-pyrrolidine-3',3''-piperidin]-4''-one.
| S-EPMC4384562 | biostudies-literature
Unknown 6'-Amino-3'-methyl-11H,2'H-spiro-[indeno-[1,2-b]quinoxaline-11,4'-pyrano[2,3-c]pyrazole]-5'-carbonitrile ethanol monosolvate.
| S-EPMC3393959 | biostudies-literature
Unknown 6-Ferrocenoyl-7-(4-fluoro-phen-yl)spiro-[hexa-hydro-pyrrolo-[1,2-c][1,3]thia-zole-5,11'-indeno-[1,2-b]quinoxaline].
| S-EPMC3884446 | biostudies-literature
Unknown 11H-Indeno-[1,2-b]quinoxalin-11-one.
| S-EPMC2979415 | biostudies-literature
Unknown {1'-Phenyl-1',2',5',6',7',7a'-hexa-hydro-spiro-[indeno-[1,2-b]quinoxaline-11,3'-pyrrolizin]-2'-yl}(p-tol-yl)methanone.
| S-EPMC3414925 | biostudies-literature
Unknown 6-Ferrocenoyl-7-phenyl-spiro-[hexa-hydro-pyrrolo-[1,2-c][1,3]thia-zole-5,11'-indeno-[1,2-b]quinoxaline].
| S-EPMC3884422 | biostudies-literature
Unknown 3-(Ferrocen-1-ylcarbon-yl)-1-methyl-4-(4-methyl-phen-yl)spiro-[pyrrolidine-2,11'-indeno-[1,2-b]quinoxaline].
| S-EPMC3470153 | biostudies-other